Follow-up and transition of care for low recurrence risk thyroid cancer patients in Canada
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.Guidelines for managing low-risk differentiated thyroid cancer (DTC) in Canada are now available. This consensus statement offers expert recommendations for initial treatment and long-term surveillance of DTC patients.
Area Of Science
- Endocrinology
- Oncology
- Public Health
Background
- Differentiated thyroid cancer (DTC) incidence has risen, prompting risk stratification (low, intermediate, high) by the American Thyroid Association (ATA).
- Low-risk DTC patients (≤5% recurrence risk) are experiencing de-escalated initial treatments, including less aggressive surgical and radioactive iodine approaches.
- Optimal long-term surveillance strategies for low-risk DTC remain undefined, despite evidence supporting primary care management.
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
